Mary T. Caserta, MD (she/her/hers)

Professor of Pediatrics, Division of Pediatric Infectious Diseases, part-time
University of Rochester Medical Center
Rochester, New York, United States

Presentation(s):

• Should We Be Adding Congenital CMV to the Universal Newborn Screening Panel? Advocacy, Policy, Progress and Controversy.

  Monday, May 6, 2024
  1:00 PM – 2:30 PM ET

  Disclosure(s): Merck (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Moderna (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

• Updated Recommendations on cCMV Diagnosis and Management: How Will the AAP COID Statement Address Universal cCMV Screening?

  Monday, May 6, 2024
  2:08 PM – 2:27 PM ET

  Disclosure(s): Merck (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Moderna (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)